Sign inJoin waitlistJoin the waitlist

Shahed Badiyan

Director of Clinical Adaptive Therapy · University of Texas Southwestern Medical Center

Credentials: · · · · · ·

History

University of Texas Southwestern Medical Center
Present

Paul Scherrer Institute
2014–2015
Radiation Oncology
Washington University School of Medicine
2010–2014
Transitional Year
John Peter Smith Hospital
2009–2010
Univ of Texas Southwestern Med Sch at Dallas
2005–2009

Research

Consensus Guidelines for Implementing Pencil-Beam Scanning Proton Therapy for Thoracic Malignancies on Behalf of the PTCOG Thoracic and Lymphoma Subcommittee
Review · International journal of radiation oncology · 2017 · 185 citations
Cardiac dose sparing and avoidance techniques in breast cancer radiotherapy
Review · Radiotherapy and Oncology · 2014 · 122 citations
Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite(®) breast brachytherapy registry trial
Annals of Surgical Oncology · 2013 · 111 citations

Clifford Robinson
22 papers
Lauren Henke
21 papers
CS
Charles Simone
18 papers
Pamela Samson
17 papers · 2 as a resident
Joshua Schiff
14 papers · 12 as a resident
Pranshu Mohindra
14 papers
Chirag Shah
12 papers · 4 as a resident
Michael Chuong
12 papers
RC
Re-I Chin
12 papers · 12 as a resident
Eric Laugeman
11 papers
Jiayi Huang
10 papers
Robert Timmerman
10 papers

Clinical trials

Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC
Principal investigator · Terminated · Phase 2
University of Texas Southwestern Medical Center
2021–2022
Durvalumab Plus "Booster" RT for Metastatic Adenocarcinoma Pancreas Cancer Post Chemotherapy (GCC 1598)
Principal investigator · Withdrawn · Phase 2
University of Maryland, Baltimore
2017–2022
Pelvic Radiotherapy With Concurrent Neoadjuvant FOLFOX for Patients With Newly Diagnosed Rectal Adenocarcinoma
Principal investigator · Terminated · Phase 2
University of Maryland, Baltimore
2015–2018
Borderline Pancreas Study: FOLFIRINOX +SBRT
Principal investigator · Completed · Early phase 1
University of Maryland, Baltimore
2014–2018